Countries
Institutions
Fields
Rankings
Compare

Search institutions, scholars, countries and publications

Sankore

Named after the University of Sankore in Timbuktu — one of the world’s oldest centres of learning. Every figure here is computed from work-level records in our own graph, never copied from a source’s summary count.

Built from

OpenAlex — works, authorships, subject classification
ROR — institutional identity
ORCID — researcher identity
Crossref — publisher confirmation

Browse

Countries
Institutions
Fields
Rankings
What we cover

Coverage is partial and says so. A country appears with its research output only once its works have been swept; until then the portal shows whatever the graph happens to hold for it and labels it as exactly that.

In vitro and in vivo suppression of SARS‐CoV‐2 replication by a modified, short, cell‐penetrating peptide targeting the C‐terminal domain of the viral spike protein

2023Journal of Medical VirologyJournalOpen access

10.1002/jmv.28626 Full text14 citations

Authors

16 authors across 7 institutions in 2 countries.

Dongbum KimFirst author
Jin-Soo Kim
as printed: Jinsoo Kim
Seungchan An
- New Generation University College (ET)
Minyoung Kim
Kyeongbin Baek
Bo Min Kang
Sony Maharjan
Suyeon Kim
Seok Young Hwang
- New Generation University College (ET)
In Guk Park
- New Generation University College (ET)
Sangkyu Park
Jun Gyo Suh
Man-Seong Park
as printed: Man‐Seong Park
Minsoo NohCorresponding
- New Generation University College (ET)
Younghee LeeCorresponding
Hyung‐Joo KwonSenior authorCorresponding

Fields

Assignment is probabilistic — a work belongs to several fields in proportions.

SARS-CoV-2 and COVID-19 Researchlevel 3 · 1.00
Antimicrobial Peptides and Activitieslevel 3 · 1.00
RNA Interference and Gene Deliverylevel 3 · 0.99

Sources

Several sources describing one work is the point — it means the record rests on more than one authority.

openalexseen September 10, 2026
2023 · Journal of Medical Virology · 14 citations
https://openalex.org/W4322719994

In vitro and in vivo suppression of SARS‐CoV‐2 replication by a modified, short, cell‐penetrating peptide targeting the C‐terminal domain of the viral spike protein · Sankore